A system for in situ generation of hormones, clotting factors or novel biopharmaceuticals.

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.2, Iss.1, 1998-07, pp. : 151-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant clotting factors to be funded by UK DoH

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 402, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Phase Transition System: Novel Oral In-Situ Gel

Current Drug Delivery, Vol. 5, Iss. 4, 2008-10 ,pp. : 282-289

Bentham Science Publishers

Access to resources Recommend Favorite

Sustained Ocular Drug Delivery from a Temperature and pH Triggered Novel In Situ Gel System

By Gupta Himanshu Jain Sanyog Mathur Rashi Mishra Pushpa Mishra Anil Velpandian T.

Drug Delivery, Vol. 14, Iss. 8, 2007-11 ,pp. : 507-515

Informa Healthcare

Access to resources Recommend Favorite

Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery

By Gupta Himanshu Velpandian T. Jain Sanyog

Journal of Drug Targeting, Vol. 18, Iss. 7, 2010-08 ,pp. : 499-505

Informa Healthcare

Access to resources Recommend Favorite

Taking Advantage of Viral Immune Evasion: Virus-Derived Proteins Represent Novel Biopharmaceuticals

Current Medicinal Chemistry, Vol. 13, Iss. 3, 2006-02 ,pp. : 325-333

Bentham Science Publishers

Access to resources Recommend Favorite